Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ruben E Mujica Mota"'
Autor:
Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33672 (2012)
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.Cost-effectiveness analysis was
Externí odkaz:
https://doaj.org/article/77a1520ae5834f208c0ebd0d9106a0b8
Publikováno v:
Orthopedic Reviews, Vol 9, Iss 3 (2017)
Without clinical guideline on the optimal timing for primary total hip replacement (THR), patients often receive the operation with delay. Delaying THR may negatively affect long-term health-related quality of life, but its economic effects are uncle
Externí odkaz:
https://doaj.org/article/f1550a1d6509477999abcfb4bba030c9
Autor:
Chris Cooper, Tristan Snowsill, Irina A Tikhonova, Joanna Varley-Campbell, Ruben E. Mujica Mota, Claudius Rudin, Martin Hoyle
Publikováno v:
PharmacoEconomics. 35:363-373
The National Institute for Health and Care Excellence (NICE) invited the manufacturer of azacitidine (Celgene) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of acute myeloid leukaemia with more than 30 % bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ad1452f4cbb5c1fadf04f339e53e7b9
https://doi.org/10.1007/s40273-016-0453-5
https://doi.org/10.1007/s40273-016-0453-5
Autor:
Marcela Haasova, Helen Coelho, Jenny Lowe, Nicola Huxley, Matt Allwood, Chris Cooper, Tracey Jones-Hughes, Louise Crathorne, Rob Anderson, Tristan Snowsill, Jo Varley-Campbell, Jason Moore, Ruben E. Mujica Mota, Jaime Peters
Immunosuppression is required in kidney transplantation to prevent rejection and prolong graft survival. We conducted an economic evaluation to support England's National Institute for Health and Care Excellence in developing updated guidance on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2154e2eb4efbe778594a2ae762cceeec
https://europepmc.org/articles/PMC5837729/
https://europepmc.org/articles/PMC5837729/
Publikováno v:
Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 13:24-36
There is a lack of scientific evidence on the impact of a biomedical industry on the surrounding economy. The assessment of this issue would allow policy makers to identify the impact on production, local employment and wages in addition to public se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a7f63315d5380a53ff833e153fc0f7
https://doi.org/10.1177/1745790412468930
https://doi.org/10.1177/1745790412468930
Publikováno v:
Journal of Medical Economics. 10:297-308
SummaryThis observational database study estimates the comparative cost effectiveness of salbutamol when delivered via a pressurised metered-dose inhaler (pMDI) or breath-actuated metered-dose inhaler (BAI) in patients with mild intermittent asthma w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52a02ec61dfd23433de525ae35268f57
https://doi.org/10.3111/13696990701551298
https://doi.org/10.3111/13696990701551298
Publikováno v:
BMC Health Services Research, Vol 12, Iss 1, p 225 (2012)
BMC Health Services Research
BMC Health Services Research
Background Documented age, gender, race and socio-economic disparities in total joint arthroplasty (TJA), suggest that those who need the surgery may not receive it, and present a challenge to explain the causes of unmet need. It is not clear whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1fccaca0bab2cd9c6b22188440b4b9
http://www.biomedcentral.com/1472-6963/12/225
http://www.biomedcentral.com/1472-6963/12/225
Publikováno v:
The American journal of tropical medicine and hygiene. 81(6)
Informal sources of care may lead to ineffective use of antimalarial drugs. A survey conducted in Malawi estimated the frequency of use of informal and formal services, medications, and household costs. A total of 508 household interviews were conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99648d2bfdbec3c1032a9030ddad6680
https://pubmed.ncbi.nlm.nih.gov/19996420
https://pubmed.ncbi.nlm.nih.gov/19996420
Autor:
Paul Dieppe, Ruben E. Mujica Mota
Publikováno v:
Rheumatology. 52:1737-1738
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a7fbb3b274ea140064530bb160279c
https://doi.org/10.1093/rheumatology/ket242
https://doi.org/10.1093/rheumatology/ket242
Autor:
Dominique Dubois, Gareth J. Morgan, Alan Haycox, Ruben E. Mujica Mota, Ravinder Dhawan, Adrian Bagust, Patrick Chu, Angela Boland
Publikováno v:
Blood. 104:268-268
Bortezomib (VELCADE), a new proteasome inhibitor, was recently licensed by the FDA for treating patients with relapsed and refractory multiple myeloma (MM), and has now also been approved for similar use in Europe. A model was developed to evaluate a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3395f7cd040947d3396753613da054bd
https://doi.org/10.1182/blood.v104.11.268.268
https://doi.org/10.1182/blood.v104.11.268.268